Perceptive Advisors »

Helix Acquisition Corp Ii Cl A shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.2M 500k 10.40

More positions owned by Perceptive Advisors

Cerevel Therapeutics Hldng I (CERE)
Amicus Therapeutics (FOLD)
Iovance Biotherapeutics (IOVA)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Inhibrx (INBX)
Fusion Pharmaceuticals (FUSN)
Rhythm Pharmaceuticals (RYTM)
Vaxcyte (PCVX)
Soleno Therapeutics (SLNO)
Medtronic SHS (MDT)
Madrigal Pharmaceuticals (MDGL)
Springworks Therapeutics (SWTX)
Neurocrine Biosciences (NBIX)

View all positions for Perceptive Advisors

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Adage Capital Partners GP
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Commodore Capital
Perceptive Advisors
Dr. Jeffrey R. Jay, M.D.
Soros Fund Management
ADAR1 Capital Management
T. Rowe Price Investment Management
Laurion Capital Management

View all funds holding Helix Acquisition Corp Ii Cl A